Clinical trial
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
NCT06548607
Study timeline
Study start (actual)2024-09-14Date precision: day
Registry last updated2026-03-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
SLE (Systemic Lupus)unresolved
Systemic Sclerosisunresolved
ANCA Associated Vasculitisunresolved
Idiopathic Inflammatory Myopathiesunresolved
Sjogren's Syndromeunresolved
Autoimmune Diseasesunresolved
Interventions
Sponsors & collaborators
Nanjing Bioheng Biotech Co., Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06548607 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.